SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-18-025692
Filing Date
2018-05-07
Accepted
2018-05-07 16:19:57
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-1/A tv493040_f1a.htm F-1/A 1713440
2 EXHIBIT 1.1 tv493040_ex1-1.htm EX-1.1 231860
3 EXHIBIT 5.1 tv493040_ex5-1.htm EX-5.1 24532
4 EXHIBIT 10.10 tv493040_ex10-10.htm EX-10.10 62605
5 EXHIBIT 23.1 tv493040_ex23-1.htm EX-23.1 4480
6 GRAPHIC tv491315_logo.jpg GRAPHIC 31528
7 GRAPHIC tv491315_img01.jpg GRAPHIC 9894
8 GRAPHIC tv491315_img02.jpg GRAPHIC 76241
9 GRAPHIC tv491315_img04.jpg GRAPHIC 5682
10 GRAPHIC tv491315_img05.jpg GRAPHIC 43826
11 GRAPHIC image_003.jpg GRAPHIC 15110
12 GRAPHIC image_004.jpg GRAPHIC 5682
  Complete submission text file 0001144204-18-025692.txt   2297733
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: F-1/A | Act: 33 | File No.: 333-221899 | Film No.: 18811478
SIC: 2834 Pharmaceutical Preparations